Neuroprotection in subarachnoid hemorrhage.

Journal Article (Journal Article;Review)

Despite advances in aneurysm ablation and the initial management of patients presenting with aneurysmal subarachnoid hemorrhage, delayed cerebral ischemia remains a significant source of morbidity. Traditionally, delayed cerebral ischemia was thought to be a result of vasospasm of the proximal intracranial vessels, and clinical trials have relied largely on radiographic evidence of vasospasm as a surrogate for functional outcome. However, a number of trials have demonstrated a dissociation between angiographic vasospasm and outcome, and more recent data suggest that other mechanisms of injury, such as microvascular dysfunction and complex neuronal-glial interactions, may influence the development of delayed ischemic deficit after aneurysmal subarachnoid hemorrhage. Our evolving understanding of the pathophysiology of delayed cerebral ischemia may offer the opportunity to test new therapeutic strategies in this area and improve clinical trial design.

Full Text

Duke Authors

Cited Authors

  • Laskowitz, DT; Kolls, BJ

Published Date

  • October 2010

Published In

Volume / Issue

  • 41 / 10 Suppl

Start / End Page

  • S79 - S84

PubMed ID

  • 20876512

Pubmed Central ID

  • PMC3376008

Electronic International Standard Serial Number (EISSN)

  • 1524-4628

Digital Object Identifier (DOI)

  • 10.1161/STROKEAHA.110.595090


  • eng

Conference Location

  • United States